Autologous stem cell transplantation (ASCT) or whole-brain radiotherapy (WBRT) as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with newly diagnosed primary cns lymphoma (PCNSL): results of the IELSG32 randomized Phase II Trial.
Authors
Ferreri, ACwynarski, K
Pulczynski, E
Fox, C
Schorb, E
La Rosee, P
Binder, M
Fabbri, A
Torri, V
Falautano, M
Ilariucci, F
Ambrosetti, A
Roth, A
Hemmaway, C
Johnson, P
Linton, Kim M
Pukrop, T
Gorlov, J
Balzarotti, M
Hess, G
Keller, U
Stilgenbauer, S
Panse, J
Tucci, A
Orsucci, L
Pisani, F
Levis, A
Krause, S
Schmoll, H
Hertenstein, B
Zaccaria, A
Guarini, A
Atta, J
Bassan, R
Cervetti, J
Elter, T
Enggaard, L
Haenel, M
Kneba, M
Liberati, M
Martelli, M
Martens, U
Morra, E
Pinto, A
Zaja, F
Ponzoni, M
Deckert, M
Politi, L
Finke, J
Reni, M
Cavalli, F
Zucca, E
Illerhaus, G
Affiliation
IRCCS San Raffaele Scientific Institute, Milano, ItalyIssue Date
2017